RNAseq analysis reveals prominent and distinct expressed variants that are related to disease severity in SARS-CoV-2 infected patients with mild-to-severe disease

Javan Okendo, David Okanda
doi: https://doi.org/10.1101/2022.03.26.22272977

Article Information

doi 
https://doi.org/10.1101/2022.03.26.22272977
History 
  • March 27, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Javan Okendo1,* and
  2. David Okanda2
  1. 1Systems and Chemical Biology Division, Department of Integrative Biomedical Sciences, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Anzio Road Observatory, Cape Town, 7925, South Africa
  2. 2Research, Innovations, and Academics Unit, Tunacare Services Health Providers Limited, Nairobi, Kenya
  1. ↵*Corresponding author Dr. Javan Okendo, Email: oknjav001{at}myuct.ac.za, Systems and Chemical Biology Division, Department of Integrative Biomedical Sciences, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Anzio Road Observatory, Cape Town, 7925, South Africa
Back to top
Posted March 27, 2022.
Download PDF
Data/Code
Email
RNAseq analysis reveals prominent and distinct expressed variants that are related to disease severity in SARS-CoV-2 infected patients with mild-to-severe disease
Javan Okendo, David Okanda
medRxiv 2022.03.26.22272977; doi: https://doi.org/10.1101/2022.03.26.22272977
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area